Resumen Introducción y objetivos

1^ Nademanee K, Veerakul G, Mower M, Likittanasombat K, Krittayapong R, Bhuripanyo K, Sitthisook S, Chaothawee L, Lai MY,Azen SP. Defibrillator Versus beta-Blockers for Unexplained Death in Thailand (DEBUT): a randomized clinical trial. Circulation. 2003; 107: 2221–2226.

2^ Belhassen B, Glick A, Viskin S. Efficacy of quinidine in high-risk patients with Brugada syndrome. Circulation. 2004; 110: 1731–1737.

3^ Nagase S, Kusano KF, Morita H, Fujimoto Y, Kakishita M, Nakamura K, Emori T, Matsubara H, Ohe T. Epicardial electrogram of the right ventricular outflow tract in patients with the Brugada syndrome: using the epicardial lead. J Am Coll Cardiol. 2002;39:1992–1995.

4^ Antzelevitch C, Brugada P, Borggrefe M, Brugada J, Brugada R, Corrado D, Gussak I, LeMarec H, Nademanee K, Perez Riera AR, Shimizu W, Schulze-Bahr E, Tan H,

5^ Buncha Sunsaneewitayakul, Yan Yao, Suthasinee Thamaree, and Shu Zhang. Endocardial Mapping and Catheter Ablation for Ventricular Fibrillation Prevention in Brugada Syndrome. J Cardiovasc Electrophysiol 2012; Vol. pp. 1-7

6 ^ Nademanee K, Veerakul G, Chandanamattha P, Chaothawee L, Ariyachaipanich A, Kriengkrai Jirasirirojanakorn, Likittanasombat K, Bhuripanyo K and Ngarmukos T. Prevention of Ventricular Fibrillation Episodes in Brugada Syndrome by CatheterAblation Over the Anterior Right Ventricular Outflow Tract Epicardium. Circulation, 2011; 123: 1270-1279.

7^ Postema PG, van Dessel PF, de Bakker JM, Dekker LR, Linnenbank AC, Hoogendijk MG, Coronel R. Tijssen JG, Wilde AA, Tan HL. Slow and discontinuous conduction conspire in Brugada syndrome: a right ventricular mapping and stimulation study. Circ Arrhythmia Electrophysiol. 2008; 1 :379 –386.

8^ Antzelevitch C. The Brugada syndrome: ionic basis and arrhythmia mechanisms. J Cardiovasc Electrophysiol 2001; 12:268 –72.

9^ Haissaguerre M, Extramiana F, Hocini M, Cauchemez B, Jais P, Cabrera J, Farre G, Leenhardt A, Sanders P, Scavee C, Hsu LF, Weerasooriya R, Shah D, Frank R, Maury P, Garrigue S, Clementy J. Mapping and ablation of ventricular fibrillation associated with long-QT and Brugada syndromes. Circulation. 2003;108:925–928.

10^ Bébarová M, Arrhythmogenesis in Brugada syndrome: Impact and constrains of current concepts, International Journal of Cardiology (2013), Article in press. http://dx.doi.org/10.1016/j.ijcard.2012.12.019

11^ Martínez-Palomo A, Alanis J, Benitex D. Transitional cardiac cells of the conductive system of the dog heart: distinguishing morphological and electrophysiological features. J Cell Biol 1970; 47: 1-17.

12^ Tranum-Jaensen J,Wilde AAM, Vremeulen JT et al. Morphology of electro-physiologicslly identified junctions between Purkinje fibers and ventricular muscle in rabbit and pig hearts. Circ Res 1991; 69: 429-437.

13^ Myerburg RJ, Stewart JW ,Hoffman BF. Electrophysiological properties of the canine peripheral A-V conducting system. Circ Res, 1970; 26: 361-378.

14^ Sasyniuk B I, Mèndez C A mechanism for rentry in canineventricular tissue. Circ. Res.1971, 28: 3-15.

15^ Yokoshiki H, Mitsuyama H, Watanabe M, Sakurai M, Tsutsui H. Pleomorphic ventricular tachycardia originating from Purkinje fiber network of left anterior fascicle. J. Electrocardiology, 2010; 43: 452-458.

16^ Poelzing S, Akar F G, Baron E, and Rosenbaum D S. Heterogeneous connexin43 expression produces electrophysiological heterogeneities across ventricular wall. Am J Physiol Heart Circ Physiol, 2004; 286: H2001–H2009.

17^ Kucera J P, Rohr S, Rudy Y. Localization of Sodium Channels inIntercalated Disks Modulates Cardiac Conduction. Circulation Research 2002, 91:1176-1182.

18^ Van Veen T A B, van Rijen H V M, Opthof T. Cardiac gap junction channels: modulation of expression and channel properties. Cardiovascular Research, 2001; 51:217–229.

19^ Elizari MV,Levi R, Acunzo RS,Chiale PA,Civetta MM,Ferreiro M,Sicouri S. Abnormal expression of cardiac neural crest cells in heart development: A different hypotesis for the etiopathogenesis of Brugada síndrome. Heart Rhythm,2007; vol 4, Nº 3: 359-365.

20^ Meregalli PG, Wilde AA, Tan HL. Pathophysiological mechanisms of Brugada syndrome: depolarization disorder, repolarization disorder, or more? Cardiovasc Res., 2005; 67:367–378.

21^ Di Diego JM, Cordeiro JM, Goodrow RJ, Fish JM,Zygmunt AC, Pérez GJ, et al. Ionic and cellular basis for the predominance of the Brugada syndrome phenotype in males. Circulation, 2002; 106: 2004-2011.

22^ Shah A J, Hocini M, Lamaison D, Sacher F, Derval N, and Haissaguerre. Regional Substrate Ablation Abolishes Brugada Syndrome. J Cardiovasc. Electrophysiol., 2011; Vol. 22, pp. 1290-1291.

23^ ) Brugada J, Brugada R, Brugada P. Determinants of sudden cardiac death in individuals with the electrocardiographic pattern of Brugada syndrome and no previous cardiac arrest. Circulation, 2003; 108: 3092 – 3096.

24^ Probst V, Veltmann C, Eckardt L, Meregalli PG, Gaita F, Tan HL, et al. Long-term prognosis of patients diagnosed with Brugada syndrome: Results from the FINGER Brugada Syndrome Registry. Circulation, 2010; 121: 635 643.

25^ Priori SG, Gasparini M, Napolitano C, Della Bella P, Ottonelli AG, Sassone B, et al. Risk Stratification in Brugada Syndrome: Results of the PRELUDE (PRogrammed ELectrical stimUlation preDictive valuE) Registry. J Am Coll Cardiol, 2012; 59: 37 45.

26^ Priori SG, Napolitano C, Gasparini M, Pappone C, Della Bella P, Giordano U, et al. Natural history of Brugada syndrome: Insights for risk stratification and management. Circulation, 2002; 105: 1342 –1347.

27^ Zipes DP, Camm AJ, Borggrefe M, Buxton AE, Chaitman B, Fromer M, et al; American College of Cardiology/American Heart Association Task Force; European Society of Cardiology Committee for Practice Guidelines; European Heart Rhythm Association; Heart Rhythm Society. ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation, 2006; 114: e385 – e484.